The M2M wins big because most people get it. 80% or more. Think of all the vials that would be sold. It’s not for naught NP made the deal with Samsung for up to 3.6 MM vials for just this year only. Whether the second wave is more virulent or not, M2M will be needed. For everyone’s sake, I hope it will be less deadly.